Om

Alamar Biosciences Inc. is a proteomics company focused on developing tools for protein biomarker detection and analysis. Its core platform, NULISA technology, supports ultra-sensitive liquid biopsy workflows designed to measure disease-related proteins from small biofluid samples. The company offers instruments, consumables, assays, and related services built around its precision proteomics platform, including the ARGO high-throughput system and NULISAseq and NULISAqpcr assay products. Alamar Biosciences serves research and translational science customers across immunology, neurology, oncology, and other areas of disease research. Its products are used by academic institutions, biopharmaceutical companies, contract research organizations, and service laboratories that need high-plex protein analysis for biomarker discovery and diagnostic development. Based in Fremont, California, Alamar Biosciences plays a specialized role in the life sciences tools market by enabling advanced protein detection for early disease research and clinical innovation.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ALAMAR BIOSCIENCES MED ENDAVU: Køb Alamar Biosciences ($ALMR) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Alamar Biosciences, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.